PPARβ/δ activation protects against hepatic ischaemia–reperfusion injury
Liver International · 2023-12 · 43 (12) · 2808-2823
DOI: 10.1111/liv.15760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 13.10.2023. Verfasst von Baolin Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimally Invasive Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: PPAR-beta, PPAR delta, Reperfusion Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: The Natural Science Foundation of Heilongjiang Province of China, Outstanding Youth Training Fund from Academician Yu Weihan of Harbin Medical University, Scientific Foundation of the First Affiliated Hospital of Harbin Medical University.
Abstract (Originalsprache)
Background and Aims Hepatic ischaemia/reperfusion injury (HIRI) is a pathophysiological process that occurs during the liver resection and transplantation. Reportedly, peroxisome proliferator‐activated receptor β/δ (PPARβ/δ) can ameliorate kidney and myocardial ischaemia/reperfusion injury. However, the effect of PPARβ/δ in HIRI remains unclear.
Methods
Mouse hepatic ischaemia/reperfusion (I/R) models were constructed for in vivo study. Primary hepatocytes and Kupffer cells (KCs) isolated from mice and cell anoxia/reoxygenation (A/R) injury model were constructed for in vitro study. Liver injury and inflammation were investigated. Small molecular compounds (GW0742 and GSK0660) and adenoviruses were used to interfere with PPARβ/δ.
Results
We found that PPARβ/δ expression was increased in the I/R and A/R models. Overexpression of PPARβ/δ in hepatocytes alleviated A/R‐induced cell apoptosis, while knockdown of PPARβ/δ in hepatocytes aggravated A/R injury. Activation of PPARβ/δ by GW0742 protected against I/R‐induced liver damage, inflammation and cell death, whereas inhibition of PPARβ/δ by GSK0660 had the opposite effects. Consistent results were obtained in mouse I/R models through the tail vein injection of adenovirus‐mediated PPARβ/δ overexpression or knockdown vectors. Furthermore, knockdown and overexpression of PPARβ/δ in KCs aggravated and ameliorated A/R‐induced hepatocyte injury, respectively. Gene ontology and gene set enrichment analysis showed that PPARβ/δ deletion was significantly enriched in the NF–κB pathway. PPARβ/δ inhibited the expression of p‐IKBα and p‐P65 and decreased NF–κB activity.
Conclusions
PPARβ/δ exerts anti‐inflammatory and anti‐apoptotic effects on HIRI by inhibiting the NF–κB pathway, and hepatocytes and KCs may play a synergistic role in this phenomenon. Thus, PPARβ/δ is a potential therapeutic target for HIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Minimally Invasive Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Intensive Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
ORCID-Profile: Yong Ma
Förderung
- The Natural Science Foundation of Heilongjiang Province of China
- Outstanding Youth Training Fund from Academician Yu Weihan of Harbin Medical University
- Scientific Foundation of the First Affiliated Hospital of Harbin Medical University
- The National Natural Scientific Foundation of China
- Heilongjiang Postdoctoral Foundation
- Heilongjiang Province Postdoctoral Start-up Fund
- Scientific Research Innovation Fund of The First Affiliated Hospital of Harbin Medical University
- China Postdoctoral Science Foundation
Zitieren
APA
Qian, B., Wang, C., Li, X., Ma, P., Dong, L., Shen, B., Wu, H., Li, N., Kang, K., & Ma, Y. (2023). PPARβ/δ activation protects against hepatic ischaemia–reperfusion injury. Liver International, 43(12), 2808-2823. https://doi.org/10.1111/liv.15760
Vancouver
Qian B, Wang C, Li X, Ma P, Dong L, Shen B, et al. PPARβ/δ activation protects against hepatic ischaemia–reperfusion injury. Liver International. 2023;43(12):2808-2823. doi:10.1111/liv.15760
BibTeX
@article{Qian2023,
author = {Qian, Baolin and Wang, Chaoqun and Li, Xiaozhuang and Ma, Panfei and Dong, Liqian and Shen, Benqiang and Wu, Huibo and Li, Nana and Kang, Kai and Ma, Yong},
title = {PPARβ/δ activation protects against hepatic ischaemia–reperfusion injury},
journal = {Liver International},
year = {2023},
volume = {43},
number = {12},
pages = {2808--2823},
doi = {10.1111/liv.15760}
}
EUVIMED